Company: RNAC
Filing Date: 2025-01-06
Form Type: CORRESP
Source: 0001140361-25-000313
Chunk: 0

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-01-06
Form: CORRESP
Chunk 0
---
January 6, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Doris Gama

| Re: | Cartesian Therapeutics, Inc.                                      |
|     | Registration Statement on Form S-3 (the “Registration Statement”) |
|     | File No. 333-283809                                               |

Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cartesian Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on January 8, 2025, or as soon as practicable thereafter. Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone when this request for acceleration has been granted.

| Very truly yours,            |                                       |
| CARTESIAN THERAPEUTICS, INC. |                                       |
| By:                          | /s/ Carsten Brunn                     |
| Name:                        | Carsten Brunn                         |
| Title:                       | President and Chief Executive Officer |

| cc: | Brian K. Rosenzweig, Covington & Burling LLP |
|     | Sarah C. Griffiths, Covington & Burling LLP  |